From Passion Health Primary Care – Timely, Trusted, Patient-Centered
Today’s update highlights key developments in gene therapy and infectious disease surveillance. The FDA has resumed Elevidys shipments for ambulatory Duchenne patients following a temporary hold, while Texas continues to monitor a steady measles outbreak. Globally, measles resurgence remains a concern, especially in the Americas. At Passion Health, we emphasize the importance of proactive care—such as MMR vaccinations, pediatric checkups, and chronic disease management—to help patients stay ahead of these health challenges. Stay informed, and take action for a healthier tomorrow.
🇺🇸 National Updates
✅ FDA Recommends Resuming Elevidys for Ambulatory Duchenne Patients
The FDA lifted its voluntary hold on Elevidys shipments for ambulatory Duchenne muscular dystrophy patients after confirming an unrelated death in Brazil. Shipments resume immediately under close monitoring. The external hold remains for non-ambulatory patients.
✅ FDA Vaccine Chief Resigns Amid Gene-Therapy Controversy
Dr. Vinay Prasad stepped down as head of FDA’s CBER following political pressure and internal critiques regarding the handling of Elevidys safety issues. His exit is seen by analysts as destabilizing for biotech regulatory confidence.
🏥 Texas Updates
✅ Measles Outbreak Steady at ~762 Cases; Low Active Infectivity
Texas reports 762 confirmed measles cases since January, with under 1% currently infectious. Hospitalizations remain at 99, and two pediatric deaths have occurred. Wastewater testing in Travis County still detects viral markers despite limited new clinical cases.
🌍 Global Health Alerts
✅ Measles Resurgence in the Americas Region
PAHO reports over 7,100 cases and 13 deaths across nine countries in 2025, concentrated among children under 5. U.S. outbreaks are central to the regional increase.
💡 Clinical Tips for Providers
• Discuss Elevidys availability and risk with eligible Duchenne patient families—ensure liver monitoring protocols are in place.
• Prioritize MMR vaccination for patients in or near outbreak zones; use wastewater signals to reinforce urgency.
• Include measles questions—fever, rash, international or state travel—in evaluations for pediatric and international patients.
